Episode 37: Clinical Conversations: Anti-Obesity Medicines Under Development

April 19, 2021 00:35:27
Episode 37: Clinical Conversations: Anti-Obesity Medicines Under Development
Obesity: A Disease
Episode 37: Clinical Conversations: Anti-Obesity Medicines Under Development

Apr 19 2021 | 00:35:27

/

Show Notes

In this episode, obesity medicine specialist and OMA Clinical Education Director, Nicholas Pennings, DO, FOMA, Dipl. ABOM interviews Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC, a highlighted speaker from Overcoming Obesity 2020 – Virtual, about new pharmaceutical agents in development to treat obesity. Topics covered include why anti-obesity medicines may be necessary in treatment, treatment targets and efficacy of newer pharmaceutical agents, role of combination medications in treatment, and a discussion about stigma and bias around anti-obesity medications.

You can access more information about Obesity Medicine podcasts and other resources from the clinical leader in Obesity Medicine at www.obesitymedicine.org/podcasts.

Episode Guests

Nicholas Pennings, DO, FOMA, Dipl. ABOM

Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC

Resources Mentioned

Anti-Obesity Medications in the Pipeline Lecture

Other Episodes

Episode 0

May 16, 2023 00:25:51
Episode Cover

Episode 82: Clinical Conversations: Phenotype-Guided Lifestyle Interventions for Obesity

In this episode, Obesity Medicine Specialist and OMA Clinical Education Director Dr. Nicholas Pennings and Dr. Andreas Acosta discuss the importance of aligning appropriate...

Listen

Episode 0

December 07, 2020 00:14:49
Episode Cover

Episode 28: Article Reviews: PCOS and Obesity

Episode Description n this episode, OMA Chief Science Officer, Harold Bays, MD, FOMA Dipl. ABOM and Sandra Christensen, MNS, ARNP, FOMA, discuss a recent...

Listen

Episode 0

August 07, 2023 00:17:15
Episode Cover

Episode 85: Article Review: Obesity, Diabetes Mellitus, and Cardiometabolic Risk with Dr. Bindlish, Part 1 of 3

In this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Shagun Bindlish, MD. Our experts...

Listen